[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100629790":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":24,"responsibleParty":35,"collaborators":37,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":24,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":24,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":24,"overallStatus":59,"whyStopped":24,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":24},{"fullName":5,"class":6},"Fresenius Kabi","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A (Treatment sequence: Glucose, ONS, Glucose, ONS, Glucose, ONS)","OTHER","Participants will receive the test product and the control product alternately. They will be randomly assigned to one of the two treatment sequence groups with 15 participants in each group. The randomization will be stratified by race\u002Fethnicity (Chinese, Caucasian).",[13,14],"Dietary Supplement: ONS","Other: glucose",{"label":16,"type":10,"description":11,"interventionNames":17},"Group B (Treatment sequence: ONS, Glucose, ONS, Glucose, ONS, Glucose)",[13,14],[19,25],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DIETARY_SUPPLEMENT","ONS","Each administration of the test product (ONS) will represent 25 g of glycaemic carbohydrates.",[9,16],null,{"type":10,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"glucose","The test product will be compared with the reference product glucose (glucose monohydrate dissolved in 250 ml water). Each administration of the reference product will represent 25 g of glycaemic carbohydrates.",[9,16],[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Sangeetha Thondre, Dr","CONTACT","+44 1865 534136","pthondre@brookes.ac.uk",{"type":36,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[38],{"name":39,"class":10},"Oxford Brookes University","100629790","glycaemic-index-measurement-of-an-oral-nutritional-supplement-with-biomarker-assessment-and-lifestyle-monitoring-in-healthy-participants-100629790",false,"NCT07479251","Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants","Inclusion Criteria:\n\n* Aged ≥18 and ≤60 years, adult healthy Caucasian or Chinese participants\n* Stable body weight within the Body Mass Index between 18.5 kg\u002Fm2 and 27.9 kg\u002Fm2 (inclusive)\n* Glycated hemoglobin \\\u003C 6%\u002F\\\u003C 42 mmol\u002Fmol\n\nExclusion Criteria:\n\n* Pregnant or lactating,\n* Body fat percentage exceeding 30%,\n* Known history of metabolic diseases or diabetes mellitus,\n* Major medical or surgical event requiring hospitalization within the preceding 3 months\n* Medical condition(s) or medication(s) or herbal effects known to affect glucose regulation, tolerance or appetite and\u002For which influence digestion and absorption of nutrients (excluding oral contraceptives),\n* Use of steroids, protease inhibitors, amphetamines or antipsychotics",true,"ALL","18 Years","60 Years",{"count":51,"type":52},30,"ESTIMATED","INTERVENTIONAL",[55],"NA","This clinical trial evaluates the postprandial glycaemic response to an Oral Nutritional Supplement (ONS), a Food for Special Medical Purposes (FSMP), in healthy adults. The study uses a crossover design comparing the ONS to the reference product glucose.\n\nEach participant will consume both test and reference products on three separate occasions each, overall on six test days.",[58],"Healthy Participants","NOT_YET_RECRUITING","2026-03-19",{"date":62,"type":63},"2026-03-23","ACTUAL",{"date":65,"type":52},"2026-03",{"date":67,"type":52},"2026-12",{"name":5,"class":6}]